IBX 2.13% 4.6¢ imagion biosystems limited

[VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers, page-42

  1. 170 Posts.
    lightbulb Created with Sketch. 56
    You ask a question on 2c CR and predict the US trial will commence in Q2 2023. IMO if we're heading for Q22023 trial, it assumes successful results in Phase1 trial. In that case, the CR will be way above current price. We may even get non dilutionary capital from a potential partner.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
-0.001(2.13%)
Mkt cap ! $1.979M
Open High Low Value Volume
4.7¢ 4.7¢ 4.6¢ $14.05K 300.3K

Buyers (Bids)

No. Vol. Price($)
1 20000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.8¢ 45938 2
View Market Depth
Last trade - 13.42pm 11/11/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.